Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells

BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway

(2018) Melissa M. Ledet et al.   BMC CANCER

Overcoming endocrine resistance in hormone receptor–positive breast cancer

(2018) A. AlFakeeh et al.   Current Oncology

Histone citrullination represses miRNA expression resulting in increased oncogene mRNAs in somatolactotrope cells

(2018) Stanley B. DeVore et al.   MOLECULAR AND CELLULAR BIOLOGY

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

(2018) Yinghua Zhu et al.   Nature Communications

Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription

(2018) Priyanka Sharma et al.   MOLECULAR CELL

Census and evaluation of p53 target genes

(2017) M Fischer   ONCOGENE

PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling

(2016) Huifeng Wang et al.   Cancer Cell International

Toxicities of docetaxel: original drug versus generics—a comparative study about 81 cases

(2016) Choukri Elm’hadi et al.   SpringerPlus

Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array

(2015) V. Vathipadiekal et al.   CLINICAL CANCER RESEARCH

Progress on the relationship between miR-125 family and tumorigenesis

(2015) Hang Yin et al.   EXPERIMENTAL CELL RESEARCH

Outcomes and endpoints in trials of cancer treatment: the past, present, and future

(2015) Michelle K Wilson et al.   LANCET ONCOLOGY

ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells

(2015) S. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin

(2015) MENG SHEN et al.   ONCOLOGY REPORTS

Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage

(2014) Laura A. Tollini et al.   CANCER CELL

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Tamoxifen Resistance in Breast Cancer

(2012) Min-Sun Chang   Biomolecules & Therapeutics

Identification of PADI2 as a potential breast cancer biomarker and therapeutic target

(2012) John L McElwee et al.   BMC CANCER

mTORC1 and p53

(2012) Paul Hasty et al.   CELL CYCLE

Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity

(2012) Yuji Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

(2012) Christina Curtis et al.   NATURE

Potential Role for PAD2 in Gene Regulation in Breast Cancer Cells

(2012) Brian D. Cherrington et al.   PLoS One

Protein arginine deiminase 4: a target for an epigenetic cancer therapy

(2010) Jessica L. Slack et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression

(2010) P Li et al.   ONCOGENE

American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   Journal of Oncology Practice

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status

(2009) Anthony Gonçalves et al.   ANTI-CANCER DRUGS

Increased PADI4 expression in blood and tissues of patients with malignant tumors

(2009) Xiaotian Chang et al.   BMC CANCER

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function

(2009) I A Ciechomska et al.   ONCOGENE

HAMLET (human α-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death

(2008) Sonja Aits et al.   INTERNATIONAL JOURNAL OF CANCER

Histone Arg Modifications and p53 Regulate the Expression ofOKL38, a Mediator of Apoptosis

(2008) Hongjie Yao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4

(2008) P. Li et al.   MOLECULAR AND CELLULAR BIOLOGY